Aspirin-treated supernatants of WT, but not CNTF−/−, astrocytes protect mouse oligodendrocytes from TNF-α insult. A–H, mouse oligodendrocytes preincubated with conditioned supernatants of untreated and aspirin (Asp)-treated WT and CNTF−/− astrocytes for 1 h were challenged with 20 ng/ml TNF-α for 6 h followed by monitoring apoptosis by TUNEL and GalC double labeling. DAPI was used to visualize the nucleus (A, control; B, TNF-α; C, TNF-α + aspirin-treated WT astroglial supernatant (sup); D, TNF-α + control WT astroglial supernatant; E, TNF-α + aspirin-treated CNTF−/− astroglial supernatant; F, TNF-α + control CNTF−/− astroglial supernatant; G, aspirin-treated WT astroglial supernatant only; H, aspirin-treated CNTF−/− astroglial supernatant only). Results represent three independent experiments. After 18 h of TNF-α challenge, cell death of oligodendrocytes was assayed by MTT (I) and LDH (J). Results are mean ± S.D. of three different experiments. a, p < 0.05 versus control; b, p < 0.05 versus TNF-α; c, p < 0.001 versus control; d, p < 0.001 versus TNF-α.